2025-07-26 - Analysis Report
Okay, here's a comprehensive analysis of Albemarle Corp (ALB) based on the provided data, formatted in English with concise numerical summaries and subsequent analysis.

## Albemarle Corp (ALB) Analysis

Albemarle Corp (ALB) is a specialty chemicals manufacturing company with a focus on lithium, bromine specialties, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

*   **ALB Cumulative Return:** 39.19%
*   **VOO Cumulative Return:** 99.66%
*   **Absolute Divergence:** -58.7
*   **Relative Divergence:** 7.8 (Indicates ALB is positioned near the bottom end of its historical divergence range compared to VOO)

**Analysis:** ALB has significantly underperformed the S&P 500. The relative divergence suggests that this underperformance is near the lower end of its historical range compared to the S&P 500.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta   | Cap(B) |
|------------|---------|-------|---------|--------|--------|
| 2015-2017  | 99.0%   | 8.1%  | 70.0%   | 0.0    | 15.1   |
| 2016-2018  | 13.0%   | 58.0% | -5.0%   | 0.0    | 9.1    |
| 2017-2019  | -44.0%  | 58.0% | -74.0%  | -0.0   | 8.6    |
| 2018-2020  | 101.0%  | 62.9% | 81.0%   | 0.6    | 17.4   |
| 2019-2021  | 268.0%  | 62.9% | 220.0%  | 0.6    | 27.5   |
| 2020-2022  | 239.0%  | 75.6% | 237.0%  | 0.8    | 25.5   |
| 2021-2023  | -53.0%  | 77.5% | -71.0%  | 0.6    | 17.0   |
| 2022-2024  | -200.0% | 77.5% | -225.0% | 0.7    | 10.1   |
| 2023-2025  | -309.0% | 77.5% | -360.0% | 3.0    | 9.8    |

**Analysis:** The table highlights periods of high growth (e.g., 2019-2021, 2020-2022) and significant downturns (e.g., 2022-2024, 2023-2025). Recent years show substantial negative alpha, indicating ALB is underperforming relative to its risk-adjusted benchmark.  Beta fluctuates but has generally increased in recent periods, suggesting increasing sensitivity to market movements. High MDD values indicate significant drawdowns during certain periods.

### 2. Recent Price Action

*   **Current Price:** $83.74
*   **Previous Close:** $84.18
*   **Change:** -$0.52
*   **5-day Moving Average:** $81.42
*   **20-day Moving Average:** $72.46
*   **60-day Moving Average:** $63.73

**Analysis:** The price is slightly down from the previous close.  The moving averages indicate a recent upward trend, with the 5-day average above the 20-day and 60-day averages. This suggests short-term bullish momentum.

### 3. Technical Indicators

*   **Market Risk Indicator (MRI):** 0.3301 (Low Risk)
*   **RSI:** 73.77 (Overbought)
*   **PPO:** 1.33
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Delta Previous Relative Divergence (20-day):** 4.9 (Positive, indicating short-term improvement)
*   **Expected Return (%):** 1388.4 (Long-term, S&P 500 Outperformance)

**Analysis:** The MRI indicates a low-risk environment. However, the RSI is in overbought territory, suggesting a potential pullback. The Hybrid Signal suggests buying a portion of cash while remaining cautious. The positive change in relative divergence indicates recent outperformance compared to its past. The extremely high expected return should be interpreted cautiously as it relies on long-term projections.

### 4. Recent News & Significant Events

*   **[2025-07-24]:** Major business developments, regulatory changes, or market events impacting Albemarle Corp.
*   **[2025-07-25]:** Analysts discussing recent performance and outlook amid industry and global economic factors.
*   **[2025-07-26]:** Stock showing notable volatility due to recent news, earnings reports, or executive actions.
*   **[2025-07-23]:** Market experts highlighting risks and opportunities, advising investors to monitor news.

**Analysis:** Recent news suggests potential volatility and significant events impacting the company. Analysts are actively discussing the stock, and monitoring news is crucial.

### 5. Recent Earnings Analysis

| Date       | EPS   | Revenue      |
|------------|-------|--------------|
| 2025-04-30 | 0     | 1.08 B$      |
| 2024-11-06 | -9.45 | 1.35 B$      |
| 2024-07-31 | -1.96 | 1.43 B$      |
| 2024-05-01 | -0.08 | 1.36 B$      |
| 2025-04-30 | -0.08 | 1.36 B$      |

**Analysis:**  EPS has been mostly negative, with a significant loss in 2024-11-06. Revenue has fluctuated, showing a recent decline. This suggests potential challenges in profitability.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
|------------|-----------|---------------|
| 2025-03-31 | $1.08B    | 14.51%        |
| 2024-12-31 | $1.23B    | 11.22%        |
| 2024-09-30 | $1.35B    | -7.68%        |
| 2024-06-30 | $1.43B    | -0.74%        |
| 2024-03-31 | $1.36B    | 2.86%         |

**Capital and Profitability:**

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-03-31 | $10.03B   | 0.41%     |
| 2024-12-31 | $9.96B    | 0.76%     |
| 2024-09-30 | $10.24B   | -10.44%   |
| 2024-06-30 | $11.22B   | -1.68%    |
| 2024-03-31 | $11.53B   | 0.02%     |

**Analysis:** Revenue has shown some decline from the beginning of 2024. Profit margins have been volatile, with negative margins in some quarters. ROE has also been inconsistent, reflecting challenges in generating returns on equity. Equity has decreased over the observed period.

### 7. Overall Analysis & Summary

Albemarle (ALB) has significantly underperformed the S&P 500. Recent price action shows a short-term upward trend, but the RSI indicates it may be overbought. Financials reveal declining revenue, volatile profit margins, and inconsistent ROE. Recent news suggests potential volatility.

**Key Takeaways:**

*   **Underperformance:** ALB has lagged the broader market significantly.
*   **Volatility:** Recent news and market events point to potential volatility.
*   **Financial Concerns:** Declining revenue and inconsistent profitability are concerns.
*   **Short-Term Bullish Momentum:** Moving averages suggest a recent upward trend, but RSI is overbought.
*   **Long-Term Uncertainity:** High '기대수익(%)' is observed, but unstable financials should be considered before long-term investments.

**Recommendation:** Given the underperformance, volatility, and financial concerns, a cautious approach is warranted. Monitor news and financial reports closely before making investment decisions. The short-term bullish momentum may present trading opportunities, but the overbought RSI suggests caution.
